$SAGE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Sage Therapeutics, Inc.. Get notifications about new insider transactions in Sage Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Buy | P | 56.05 | 17,842 | 999,983 | 320,659 | 302.8 K to 320.7 K (+5.89 %) | |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 12,000 | 5,400 | 46,587 | |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 12,000 | 5,400 | 75,237 | 63.2 K to 75.2 K (+18.98 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Payment of Exercise | F | 58.80 | 3,093 | 181,868 | 63,237 | 66.3 K to 63.2 K (-4.66 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Grant | A | 0.00 | 10,000 | 0 | 66,330 | 56.3 K to 66.3 K (+17.75 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Payment of Exercise | F | 58.80 | 1,001 | 58,859 | 10,791 | 11.8 K to 10.8 K (-8.49 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Grant | A | 0.00 | 3,500 | 0 | 11,792 | 8.3 K to 11.8 K (+42.21 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 2,000 | 2,720 | 14,047 | |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 3,000 | 4,080 | 16,047 | |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 2,000 | 2,720 | 44,533 | 42.5 K to 44.5 K (+4.70 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Payment of Exercise | F | 58.80 | 822 | 48,334 | 42,533 | 43.4 K to 42.5 K (-1.90 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Grant | A | 0.00 | 3,500 | 0 | 43,355 | 39.9 K to 43.4 K (+8.78 %) |
Jun 17 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 3,000 | 4,080 | 39,855 | 36.9 K to 39.9 K (+8.14 %) |
Apr 14 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 948 | 1,289 | 0 | |
Apr 14 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 552 | 751 | 2,995 | |
Apr 14 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 1,500 | 2,040 | 36,855 | 35.4 K to 36.9 K (+4.24 %) |
Feb 12 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | A | 82.27 | 34,000 | 2,797,180 | 34,000 | |
Feb 12 2021 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 82.27 | 22,500 | 1,851,075 | 22,500 | |
Feb 12 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 82.27 | 19,000 | 1,563,130 | 19,000 | |
Feb 12 2021 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 82.27 | 19,000 | 1,563,130 | 19,000 | |
Feb 12 2021 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 82.27 | 19,000 | 1,563,130 | 19,000 | |
Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Option Exercise | M | 0.45 | 1,800 | 810 | 58,587 | |
Jan 28 2021 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | Chief Innovation Of ... | Buy | M | 0.45 | 1,800 | 810 | 56,330 | 54.5 K to 56.3 K (+3.30 %) |
Jan 06 2021 | SAGE | Sage Therapeutics, ... | Barrett Elizabeth | Option Exercise | A | 84.41 | 915 | 77,235 | 915 | ||
Jan 06 2021 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 84.41 | 832 | 70,229 | 832 | ||
Jan 06 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 1,750 | 2,380 | 948 | |
Jan 06 2021 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 1,750 | 2,380 | 35,355 | 33.6 K to 35.4 K (+5.21 %) |
Jan 06 2021 | SAGE | Sage Therapeutics, ... | Greene Barry E | President and CEO | Option Exercise | A | 85.82 | 390,000 | 33,469,800 | 390,000 | |
Jun 11 2020 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 11 2020 | SAGE | Sage Therapeutics, ... | Barrett Elizabeth | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
May 05 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 37.13 | 50,000 | 1,856,500 | 50,000 | |
May 04 2020 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 4,000 | 5,440 | 2,698 | |
May 04 2020 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 4,000 | 5,440 | 33,261 | 29.3 K to 33.3 K (+13.67 %) |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 39.87 | 15,385 | 613,400 | 15,385 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 39.87 | 15,385 | 613,400 | 15,385 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Apr 30 2020 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
Feb 14 2020 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 68.87 | 17,500 | 1,205,225 | 17,500 | |
Feb 14 2020 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 68.87 | 17,500 | 1,205,225 | 17,500 | |
Feb 14 2020 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 68.87 | 20,000 | 1,377,400 | 20,000 | |
Jan 07 2020 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 73.53 | 976 | 71,765 | 976 | ||
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 500 | 680 | 3,547 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 500 | 680 | 3,547 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 15,000 | 20,400 | 4,047 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 15,000 | 20,400 | 4,047 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 500 | 680 | 29,261 | 28.8 K to 29.3 K (+1.74 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 500 | 680 | 29,261 | 28.8 K to 29.3 K (+1.74 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 15,000 | 20,400 | 28,761 | 13.8 K to 28.8 K (+109.00 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 15,000 | 20,400 | 28,761 | 13.8 K to 28.8 K (+109.00 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 28.63 | 3,076 | 88,066 | 21,924 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 38.25 | 5,732 | 219,249 | 32,668 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 28.63 | 3,076 | 88,066 | 21,924 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 6,935 | 9,432 | 0 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 38.25 | 5,732 | 219,249 | 32,668 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 64.16 | 25,000 | 1,604,000 | 136,400 | 111.4 K to 136.4 K (+22.44 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 6,935 | 9,432 | 0 | |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 28.63 | 3,076 | 88,066 | 111,400 | 108.3 K to 111.4 K (+2.84 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 64.16 | 25,000 | 1,604,000 | 136,400 | 111.4 K to 136.4 K (+22.44 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 38.25 | 5,732 | 219,249 | 108,324 | 102.6 K to 108.3 K (+5.59 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 28.63 | 3,076 | 88,066 | 111,400 | 108.3 K to 111.4 K (+2.84 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 6,935 | 9,432 | 102,592 | 95.7 K to 102.6 K (+7.25 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 38.25 | 5,732 | 219,249 | 108,324 | 102.6 K to 108.3 K (+5.59 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | P | 64.20 | 7,500 | 481,500 | 54,530 | 47 K to 54.5 K (+15.95 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 6,935 | 9,432 | 102,592 | 95.7 K to 102.6 K (+7.25 %) |
Dec 10 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | P | 64.20 | 7,500 | 481,500 | 54,530 | 47 K to 54.5 K (+15.95 %) |
Sep 12 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 4,600 | 2,070 | 60,387 | |
Sep 12 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 4,600 | 2,070 | 47,030 | 42.4 K to 47 K (+10.84 %) |
Sep 05 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 6,000 | 2,700 | 86,100 | |
Sep 05 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 6,000 | 2,700 | 8,292 | 2.3 K to 8.3 K (+261.78 %) |
Sep 05 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | M | 0.45 | 6,000 | 2,700 | 86,100 | |
Sep 05 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Buy | M | 0.45 | 6,000 | 2,700 | 8,292 | 2.3 K to 8.3 K (+261.78 %) |
Aug 16 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | M | 28.35 | 8,000 | 226,800 | 5,922 | ||
Aug 16 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Sell | S | 160.58 | 8,000 | 1,284,640 | 2,535 | 10.5 K to 2.5 K (-75.94 %) | |
Aug 16 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Buy | M | 28.35 | 8,000 | 226,800 | 10,535 | 2.5 K to 10.5 K (+315.58 %) | |
Aug 16 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Gift | G | 0.00 | 500 | 0 | 2,535 | 3 K to 2.5 K (-16.47 %) | |
Aug 16 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Gift | G | 0.00 | 1,200 | 0 | 3,035 | 4.2 K to 3 K (-28.34 %) | |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Payment of Exercise | F | 161.38 | 1,088 | 175,581 | 2,102 | 3.2 K to 2.1 K (-34.11 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Grant | A | 0.00 | 2,450 | 0 | 3,190 | 740 to 3.2 K (+331.08 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Payment of Exercise | F | 161.38 | 1,685 | 271,925 | 42,430 | 44.1 K to 42.4 K (-3.82 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Grant | A | 0.00 | 5,000 | 0 | 44,115 | 39.1 K to 44.1 K (+12.78 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Payment of Exercise | F | 161.38 | 548 | 88,436 | 95,657 | 96.2 K to 95.7 K (-0.57 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Grant | A | 0.00 | 1,900 | 0 | 96,205 | 94.3 K to 96.2 K (+2.01 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 825 | 0 | 94,137 | 95 K to 94.1 K (-0.87 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Payment of Exercise | F | 161.38 | 549 | 88,598 | 2,292 | 2.8 K to 2.3 K (-19.32 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Grant | A | 0.00 | 1,900 | 0 | 2,841 | 941 to 2.8 K (+201.91 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Payment of Exercise | F | 161.38 | 548 | 88,436 | 13,761 | 14.3 K to 13.8 K (-3.83 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Grant | A | 0.00 | 1,900 | 0 | 14,309 | 12.4 K to 14.3 K (+15.31 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Payment of Exercise | F | 161.38 | 844 | 136,205 | 1,756 | 2.6 K to 1.8 K (-32.46 %) |
Jul 29 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Grant | A | 0.00 | 1,900 | 0 | 2,600 | 700 to 2.6 K (+271.43 %) |
Jul 25 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 2,000 | 2,720 | 6,698 | |
Jul 25 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 2,000 | 2,720 | 12,409 | 10.4 K to 12.4 K (+19.21 %) |
Jul 17 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | M | 1.36 | 4,000 | 5,440 | 8,698 | |
Jul 17 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Buy | M | 1.36 | 4,000 | 5,440 | 10,409 | 6.4 K to 10.4 K (+62.41 %) |
Jul 17 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 27,000 | 12,150 | 64,987 | |
Jul 17 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 27,000 | 12,150 | 39,115 | 12.1 K to 39.1 K (+222.86 %) |
Jun 25 2019 | SAGE | Sage Therapeutics, ... | Kanes Stephen | Chief Medical Offic ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 13,200 | |
Jun 25 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 13,200 | |
Jun 25 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | A | 47.70 | 9,240 | 440,748 | 18,480 | |
Jun 25 2019 | SAGE | Sage Therapeutics, ... | IGUCHI KIMI | CFO & Treasurer | Option Exercise | A | 47.70 | 7,425 | 354,173 | 14,850 | |
Jun 25 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | A | 47.70 | 23,100 | 1,101,870 | 46,200 | |
Jun 06 2019 | SAGE | Sage Therapeutics, ... | PAUL STEVEN M | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | Nayak Asha | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | Germano Geno J | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | FRATES JAMES M | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | COLA MICHAEL F | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | Barrett Elizabeth | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 35,736 | 16,081 | 91,987 | |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 171.39 | 475 | 81,411 | 12,115 | 12.6 K to 12.1 K (-3.77 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 170.40 | 400 | 68,158 | 12,590 | 13 K to 12.6 K (-3.08 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 169.16 | 200 | 33,832 | 12,990 | 13.2 K to 13 K (-1.52 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 177.62 | 2,545 | 452,033 | 13,190 | 15.7 K to 13.2 K (-16.17 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.44 | 11,662 | 2,057,674 | 15,735 | 27.4 K to 15.7 K (-42.57 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.72 | 16,651 | 2,925,880 | 27,397 | 44 K to 27.4 K (-37.80 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.48 | 28,293 | 4,936,667 | 44,048 | 72.3 K to 44 K (-39.11 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 173.62 | 25,510 | 4,428,934 | 72,341 | 97.9 K to 72.3 K (-26.07 %) |
May 29 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 35,736 | 16,081 | 97,851 | 62.1 K to 97.9 K (+57.53 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 40,356 | 18,160 | 127,723 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 53,908 | 24,259 | 168,079 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 177.76 | 950 | 168,872 | 62,115 | 63.1 K to 62.1 K (-1.51 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.80 | 2,518 | 445,182 | 63,065 | 65.6 K to 63.1 K (-3.84 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.79 | 3,974 | 698,589 | 65,583 | 69.6 K to 65.6 K (-5.71 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.02 | 24,966 | 4,369,549 | 69,557 | 94.5 K to 69.6 K (-26.41 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.05 | 7,948 | 1,383,349 | 94,523 | 102.5 K to 94.5 K (-7.76 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 40,356 | 18,160 | 102,471 | 62.1 K to 102.5 K (+64.97 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.15 | 1,763 | 310,552 | 62,115 | 63.9 K to 62.1 K (-2.76 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.09 | 14,727 | 2,578,550 | 63,878 | 78.6 K to 63.9 K (-18.74 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.46 | 31,099 | 5,425,532 | 78,605 | 109.7 K to 78.6 K (-28.35 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 173.41 | 4,200 | 728,322 | 109,704 | 113.9 K to 109.7 K (-3.69 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 172.20 | 1,619 | 278,792 | 113,904 | 115.5 K to 113.9 K (-1.40 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 171.01 | 500 | 85,505 | 115,523 | 116 K to 115.5 K (-0.43 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 53,908 | 24,259 | 116,023 | 62.1 K to 116 K (+86.79 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | M | 73.43 | 25,000 | 1,835,750 | 160,000 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Sell | S | 175.00 | 25,000 | 4,375,000 | 461 | 25.5 K to 461 (-98.19 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Buy | M | 73.43 | 25,000 | 1,835,750 | 25,461 | 461 to 25.5 K (+5,422.99 %) |
May 10 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | M | 56.27 | 700 | 39,389 | 109,300 | |
May 10 2019 | SAGE | Sage Therapeutics, ... | Cook Anne Marie | SVP, GC & Secretary | Option Exercise | M | 28.63 | 15,000 | 429,450 | 15,000 |